-
公开(公告)号:US20230345986A1
公开(公告)日:2023-11-02
申请号:US18014789
申请日:2021-10-26
申请人: Firmenich SA
发明人: Wen-Juan XIANG , Dan-Ting YIN
IPC分类号: A23L27/00 , C07C225/16 , C07D317/50 , C07D207/04 , C07D207/325 , C07D207/18 , C07D211/36 , C07D211/72
CPC分类号: A23L27/88 , C07C225/16 , C07D317/50 , C07D207/04 , C07D207/325 , C07D207/18 , C07D211/36 , C07D211/72
摘要: The present disclosure generally provides conjugates diynes, particularly 6,8-diyne amides, and the use of such compounds and related compounds as flavor modifiers. In some aspects, the disclosure provides compositions that include such conjugated diynes, such as compositions that include such conjugated diynes and one or more additional compounds, such as a sweetener, salt, a glutamate, an arginate, and the like. In some other aspects, the disclosure provides methods of reducing or eliminating the amount of sweetener, salt, glutamate, or arginate in a food or beverage product.
-
公开(公告)号:US10526288B2
公开(公告)日:2020-01-07
申请号:US16308312
申请日:2017-06-09
发明人: Hiromi Ishikawa , Kiyono Nakagawa , Yukiko Takeda
IPC分类号: C07D211/72 , C07D265/30 , C07D413/04 , C07D211/58 , C07B61/00
摘要: The object of the present invention is to provide a method for preparing 4-(piperidin-4-yl)morpholine, which is easy to operate. The object can be solved by a method for preparing 4-(1-benzylpiperidin-4-yl)morpholine, characterized in that 5-fold molar or more of morpholine is added to 1-benzyl-4-piperidone, and the mixture is reacted with hydrogen under 1 MPa or less in the presence of platinum catalyst or palladium catalyst.
-
公开(公告)号:US10519111B2
公开(公告)日:2019-12-31
申请号:US15888631
申请日:2018-02-05
IPC分类号: C07D211/70 , C07D211/72 , C07D211/78 , C07D401/06 , C07D401/04 , C07D223/04 , C07D207/20 , A61Q17/04 , A61K8/49 , C07F7/21 , A61K8/58 , C09D5/32 , C09D7/63 , C07D405/06 , C08K5/544 , C08K5/3432 , C08K5/41 , C08K5/3445 , C08K5/36 , C08K5/435
摘要: There is provided a range of novel compounds which have been demonstrated to have useful electromagnetic radiation absorbing properties. These compounds will find use in a range of applications such as active components in sunscreen formulations, paints, plastics, fabrics, glass and UV protective coatings.
-
公开(公告)号:US10173980B2
公开(公告)日:2019-01-08
申请号:US15570115
申请日:2016-04-29
发明人: Haoming Zhang
IPC分类号: C07D211/72 , A61K45/06 , A61K47/52 , A61P9/00 , A61K9/00 , A61K31/445 , A61K31/4525 , A61K31/4535 , A61K31/454 , A61K31/4545 , A61K31/506 , A61K31/53 , A61K31/5395 , A61K31/541 , C07D401/06 , C07D405/06 , C07D409/06 , C07D413/06 , C07D417/06 , C07D419/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D419/12
摘要: This invention is in the field of medicinal chemistry. In particular, the invention relates to mixed disulfide conjugates of thienopyridine compounds, and their use as therapeutics for the treatment, amelioration, and prevention of cardiovascular diseases.
-
公开(公告)号:US10059669B2
公开(公告)日:2018-08-28
申请号:US15524479
申请日:2015-11-09
申请人: H. Lundbeck A/S
发明人: Karsten Juhl , Lena Tagmose , Mauro Marigo
IPC分类号: C07D211/72 , C07D401/12 , C07D413/12 , A61K31/4427 , C07D417/12 , C07B59/00
CPC分类号: C07D211/72 , C07B59/002 , C07B2200/05 , C07D401/12 , C07D413/12 , C07D417/12
摘要: The present invention is directed to compounds according to Formula (I) which compounds are inhibitors of the BACE1 enzyme. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders for 5 which the reduction of Aβ deposits is beneficial such as Alzheimer's disease.
-
6.
公开(公告)号:US10011596B2
公开(公告)日:2018-07-03
申请号:US15233463
申请日:2016-08-10
申请人: H. Lundbeck A/S
发明人: Karsten Juhl , Lena Tagmose , Mauro Marigo
IPC分类号: C07D417/12 , C07B59/00 , C07D211/72 , C07D401/12 , C07D413/12 , C07D211/76
CPC分类号: C07D401/12 , C07B59/002 , C07B2200/05 , C07D211/72 , C07D211/76 , C07D413/12 , C07D417/12
摘要: The present invention provides compounds of Formula I for the treatment of neurodegenerative or cognitive diseases. The method further provides for piperidine-2-one and piperidine-2-thione intermediates to compounds of formula I.
-
公开(公告)号:US20170334853A1
公开(公告)日:2017-11-23
申请号:US15631822
申请日:2017-06-23
发明人: Haoming Zhang , Paul Hollenberg
IPC分类号: C07D211/72 , C07D405/12 , C07D401/12 , A61K45/06 , A61K31/4545 , A61K31/501 , A61K47/54 , A61K31/4525 , A61K31/445 , A61K47/64 , C07K5/093 , A61K38/06
CPC分类号: C07D211/72 , A61K31/445 , A61K31/4525 , A61K31/4545 , A61K31/501 , A61K38/06 , A61K45/06 , A61K47/54 , A61K47/542 , A61K47/545 , A61K47/64 , A61P9/00 , C07D401/12 , C07D405/12 , C07K5/0819 , A61K2300/00
摘要: This invention is in the field of medicinal chemistry. In particular, the invention relates to mixed disulfide conjugates of thienopyridine compounds, and their use as therapeutics for the treatment, amelioration, and prevention of cardiovascular diseases.
-
公开(公告)号:US09790210B2
公开(公告)日:2017-10-17
申请号:US14442604
申请日:2013-11-12
申请人: Array BioPharma Inc.
发明人: Steven Wade Andrews , James F. Blake , Barbara J. Brandhuber , Timothy Kercher , Shannon L. Winski
IPC分类号: C07D231/00 , C07D403/00 , C07D401/00 , C07D211/72 , C07D413/00 , C07D405/12 , C07D403/12 , C07D401/14 , C07D231/40 , C07D231/44 , C07D401/04 , C07D413/12 , C07D231/52 , C07D401/12 , C07D405/04 , A61K31/4155
CPC分类号: C07D405/12 , A61K31/4155 , C07D231/40 , C07D231/44 , C07D231/52 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/04 , C07D413/12
摘要: Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.
-
公开(公告)号:US09718778B2
公开(公告)日:2017-08-01
申请号:US14758736
申请日:2014-01-06
发明人: Haoming Zhang , Paul Hollenberg
IPC分类号: C07D211/72 , C07D405/12 , C07K5/093 , A61K31/445 , A61K38/06 , A61K47/48 , A61K31/501 , C07D401/12 , A61K45/06 , A61K31/4525 , A61K31/4545
CPC分类号: C07D211/72 , A61K31/445 , A61K31/4525 , A61K31/4545 , A61K31/501 , A61K38/06 , A61K45/06 , A61K47/54 , A61K47/542 , A61K47/545 , A61K47/64 , A61P9/00 , C07D401/12 , C07D405/12 , C07K5/0819 , A61K2300/00
摘要: This invention is in the field of medicinal chemistry. In particular, the invention relates to mixed disulfide conjugates of thienopyridine compounds, and their use as therapeutics for the treatment, amelioration, and prevention of cardiovascular diseases.
-
公开(公告)号:US09688693B2
公开(公告)日:2017-06-27
申请号:US14341097
申请日:2014-07-25
申请人: OPKO Health, Inc.
发明人: Sunil Paliwal , Gregory A. Reichard , Cheng Wang , Dong Xiao , Hon-Chung Tsui , Neng-Yang Shih , Juan D. Arredondo , Michelle Laci Wrobleski , Anandan Palani
IPC分类号: C07D498/10 , A61K31/40 , C07D207/14 , C07D211/28 , C07D211/32 , C07D211/42 , C07D211/56 , C07D211/60 , C07D211/72 , C07D211/76 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D413/10 , C07D413/12 , C07D471/10 , C07D487/10 , C07D491/10 , C07D513/10 , A61K31/4025 , A61K31/438 , A61K31/454 , A61K31/4545 , A61K31/5377 , A61K45/06 , C07D207/50
CPC分类号: C07D498/10 , A61K31/166 , A61K31/40 , A61K31/4025 , A61K31/437 , A61K31/4375 , A61K31/438 , A61K31/451 , A61K31/454 , A61K31/4545 , A61K31/537 , A61K31/5377 , A61K31/573 , A61K45/06 , C07D207/14 , C07D207/50 , C07D211/28 , C07D211/32 , C07D211/42 , C07D211/56 , C07D211/60 , C07D211/72 , C07D211/76 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D413/10 , C07D413/12 , C07D471/10 , C07D487/10 , C07D491/10 , C07D513/10
摘要: A NK1 antagonist having the formula (I), wherein Ar1 and Ar2 are optionally substituted phenyl or heteroaryl, X1 is an ether, thio or imino linkage, R4 and R5 are not both H or alkyl, and the remaining variables are as defined in the specification, useful for treating a number of disorders, including emesis, depression, anxiety and cough. Pharmaceutical compositions. Methods of treatment and combinations with other agents are also disclosed.
-
-
-
-
-
-
-
-
-